«We're interested in determining patients» sleep patterns,» says John Kane, head
of schizophrenia research at Zucker Hillside Hospital in Glen Oaks, N.Y. Kane, who is conducting a Proteus - funded pilot study, says, «For certain mental illnesses, changes in sleep patterns are an early sign that an illness is accelerating.»
He was also awarded the Helen Dorris Fellowship
in schizophrenia research in the department of neuropharmacology at The Scripps Research Institute.
«While a great deal of money has been invested in developing schizophrenia drugs, a similar investment hasn't been made to develop biomarkers that could improve the reliability and consistency of test results,» said Daniel Javitt, MD, PhD, professor of psychiatry and Director of the Division of Experimental Therapeutics at CUMC, Director of
schizophrenia research at the Nathan Kline Institute for Psychiatric Research, and Co-Principal Investigator of the study.
An attitude of gloom pervaded the field of
schizophrenia research for decades, with many scholars insisting that improvement was exceedingly rare, if not unheard of.
Remarkably, two compounds that seem to exert these neuroprotective effects — both of them a focus of intense interest
in schizophrenia research — aren't sophisticated drugs but simple compounds found in nature.
The field
of schizophrenia research is booming these days, thanks to the window on the brain provided by magnetic resonance imaging (MRI).
«That result has been replicated at least seven times,» says Robert K. Heinssen, chief of
the schizophrenia research program at the National Institute of Mental Health (which has funded some of Malaspina's work).
The study offers a new approach to
schizophrenia research, which has been largely stagnant for decades.
They noted that confirmation through other studies was needed before such a link could be said to be established, and they cautioned that in the history of
schizophrenia research, many apparent associations had eventually proved spurious or impossible to replicate.
Jingchun Chen (Nevada Institute of Personalized Medicine) received a UNLV IDeA Pilot Grant in the amount of $ 69,300 for her pilot study to develop a cellular model of microglia for
schizophrenia research.
An Emotional Training program «Mind Reading» developed by Researcher Simon Baron - Cohen is software designed for autistic children, but being used in
schizophrenia research and possibly of value to children at high risk of schizophrenia (i.e. a child with close family relatives who have had schizophrenia).
Importance of animal models in
schizophrenia research.